Drug interaction between St John's wort and nevirapine

被引：116

作者：

de Maat, MMR ^{[1
]}

Hoetelmans, RMW

Mathôt, RAA

van Gorp, ECM

Meenhorst, PL

Mulder, JW

Beijnen, JH

机构：

[1] Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands

[2] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands

来源：

AIDS | 2001年 / 15卷 / 03期

关键词：

D O I：

10.1097/00002030-200102160-00019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

收藏

页码：420 / 421

页数：2

相关论文

共 7 条

[1] BOECKMAN J, 1994, NONMEM USERS GUIDE 4
[2] Second thoughts about safety of St John's wort
Ernst, E
[J]. LANCET, 1999, 354 (9195) : 2014 - 2016
[3] Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)
Johne, A
Brockmöller, J
Bauer, S
Maurer, A
Langheinrich, M
Roots, I
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (04) : 338 - 345
[4] Biologically active and other chemical constituents of the herb of Hypericum perforatum L.
Nahrstedt, A
Butterweck, V
[J]. PHARMACOPSYCHIATRY, 1997, 30 : 129 - 134
[5] Indinavir concentrations and St John's wort
Piscitelli, SC
Burstein, AH
Chaitt, D
Alfaro, RM
Falloon, J
[J]. LANCET, 2000, 355 (9203) : 547 - 548
[6] VELDKAMP AI, 1999, 7 C CLIN ASP TREATM
[7] Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients
Zhou, XJ
Sheiner, LB
D'Aquila, RT
Hughes, MD
Hirsch, MS
Fischl, MA
Johnson, VA
Myers, M
Sommadossi, JP
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 121 - 128